NCT02104440

Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Red de Terapia Celular · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of the sequential infusion of allogeneic mesenchymal stem cells (MSC), expanded "in vitro" with platelet lysate without addition of animal products in the treatment of patients undergoing allo-HSCT who developed one or more cytopenias.

Conditions

• Cytopenia

Interventions

Type	Name	Description
BIOLOGICAL	Sequential infusion of allogeneic mesenchymal stem cells expanded "in vitro"

Timeline

• Start date: 2013-10-01
• Primary completion: 2017-03-01
• Completion: 2017-03-01
• First posted: 2014-04-04
• Last updated: 2017-03-30

Locations

1 site across 1 country: Spain